Develops and delivers advanced cybersecurity software to protect devices from malware and online threats for home and business users.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Malwarebytes is a leading cybersecurity company that provides advanced malware removal and protection software for both home and business users. Malwarebytes focuses on delivering comprehensive security solutions that protect devices from various online threats.
Malwarebytes Funding
Sign up to gain insights into Malwarebytes funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Dec 13, 2022 | 113M | ||
| Series B | Dec 21, 2015 | 50M | ||
| Series A | Jan 31, 2014 | 30M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Malwarebytes Management Team
Investors
Fidelity
Vector Capital
Highland Capital Partners
Malwarebytes Valuations & Financials
View real-time NPM data on Malwarebytes stock including daily Malwarebytes stock price estimates, valuation history, and historical share price information. Access Malwarebytes financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Malwarebytes pricing across six independent market signals. Looking for private company due diligence data sources on Malwarebytes? Get in touch to learn more.
Similar Companies
like Malwarebytes
Abnormal AI
Cybersecurity
Uses AI to enhance security through real-time risk assessment and automated remediation, protecting against phishing and social engineering attacks.
Illumio
Cybersecurity
Provides adaptive security platform for data centers and cloud environments, enabling dynamic policy management and traffic visualization.
Prove Identity
Cybersecurity
Secure mobile authentication offering businesses identity certainty to verify the identities of consumers and employees.
Persona
Cybersecurity
Identity infrastructure that enables businesses to craft personalized and automated identity verification solutions.
Pindrop Security
Cybersecurity
Develops advanced phone security technology to prevent call fraud and authenticate callers through comprehensive voice analysis
TRM Labs
Web3 & Digital Assets
Provides blockchain intelligence and monitoring solutions to detect cryptocurrency fraud and financial crime through risk management platform.
FAQ
We have answers
Malwarebytes stock does not trade on public stock exchanges. Malwarebytes stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Malwarebytes stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Malwarebytes Stock does not trade on public stock exchanges. In order to sell Malwarebytes shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Malwarebytes price per share was $8.62 as of June 05, 2026. This Malwarebytes share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Malwarebytes share price today and the factors driving Malwarebytes valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Malwarebytes stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Malwarebytes stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Malwarebytes stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Malwarebytes is a private company and has not had an IPO. There is currently no Malwarebytes IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Malwarebytes IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
